• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Market Research Report > Pharmaceutical > Neurodegenerative Disease

Neurodegenerative Disease Market Research Reports

We offer reports covering rare and common neurodegenerative diseases such as MS, dementia, Alzheimer’s, and epilepsy. Central nervous system drugs are covered individually in the research, which contains information regarding drug pipelines and R&D challenges, as well as assessments of market potential.

New for 2017!
Filter
Title Search
1 - 25 of 249 Products Sort by Display
Bell's Palsy Forecast in 15 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
436080
Published
February 7, 2017
Content info
62 Pages
Price
USD 6100
Sample available
Multiple Sclerosis Forecast in 18 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
425865
Published
January 26, 2017
Content info
98 Pages
Price
USD 6100
Sample available
Global Central Nervous System Partnering 2010 to 2017: Deal Trends, Players and Financials
Published by
Current Partnering, a division of Wildwood Ventures Limited
Product code
250308
Published
January 23, 2017
Content info
600+ Pages
Price
USD 2995
Sample available
Vascular Dementia Forecast in 13 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
422539
Published
January 19, 2017
Content info
50 Pages
Price
USD 6100
Sample available
Muscular Dystrophies Forecast in 12 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
422288
Published
January 18, 2017
Content info
44 pages
Price
USD 6100
Sample available
Global Myasthenia Gravis Drugs Market 2017-2021
Published by
TechNavio (Infiniti Research Ltd.)
Product code
422872
Published
January 12, 2017
Content info
73 Pages
Price
USD 3500
Sample available
Parkinson's Disease - Heat Map and Analysis
Published by
GBI Research
Product code
440736
Published
January 9, 2017
Content info
20 Pages
Price
USD 2000
Sample available
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
410989
Published
December 30, 2016
Content info
40 Pages
Price
USD 2000
Sample available
Progressive Relapsing Multiple Sclerosis (PRMS) - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
410973
Published
December 30, 2016
Content info
35 Pages
Price
USD 2000
Sample available
Multiple Sclerosis - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
232855
Published
December 21, 2016
Content info
928 Pages
Price
USD 2500
Sample available
Neurological Disorder Drugs Market (Disorder - Epilepsy, Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Cerebrovascular Disease; Drug Type) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Published by
Transparency Market Research
Product code
410942
Published
December 16, 2016
Content info
224 Pages
Price
USD 5795
Sample available
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
Published by
GBI Research
Product code
219212
Published
December 1, 2016
Content info
133 Pages
Price
USD 4995
Sample available
Rett Syndrome - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
359401
Published
October 29, 2016
Content info
122 Pages
Price
USD 2000
Sample available
Guillain-Barre Syndrome - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
332891
Published
October 29, 2016
Content info
48 Pages
Price
USD 2000
Sample available
EpiCast Report: Attention-Deficit/Hyperactivity Disorder - Epidemiology Forecast to 2024
Published by
GlobalData
Product code
392614
Published
October 14, 2016
Content info
58 Pages
Price
USD 3995
Sample available
Lower Back Pain & Sciatica Forecast in 9 Major Markets 2016-2026
Published by
Black Swan Analysis
Product code
374075
Published
October 12, 2016
Content info
46 Pages
Price
USD 6100
Sample available
Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2016
Published by
GlobalData
Product code
385650
Published
September 30, 2016
Content info
222 Pages
Price
USD 2500
Sample available
Global Central Nervous System Disorders Therapeutics Market 2016-2020
Published by
TechNavio (Infiniti Research Ltd.)
Product code
372088
Published
September 22, 2016
Content info
147 Pages
Price
USD 2500
Sample available
Huntingtin (Huntington Disease Protein or HTT) - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
358692
Published
September 21, 2016
Content info
56 Pages
Price
USD 3500
Sample available
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2016
Published by
GlobalData
Product code
307774
Published
September 21, 2016
Content info
37 Pages
Price
USD 2500
Sample available
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024
Published by
GlobalData
Product code
404472
Published
September 1, 2016
Content info
369 Pages
Price
USD 10995
Sample available
Global Alzheimer's Disease Partnering 2010 to 2016
Published by
Current Partnering, a division of Wildwood Ventures Limited
Product code
239673
Published
September 1, 2016
Content info
 
Price
USD 1495
Sample available
Neoplastic Syndrome Global Clinical Trials Review, H2, 2016
Published by
GlobalData
Product code
299743
Published
August 30, 2016
Content info
40 Pages
Price
USD 2500
Sample available
Epilepsy - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
232793
Published
August 24, 2016
Content info
421 Pages
Price
USD 2000
Sample available
Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H2, 2016
Published by
GlobalData
Product code
306655
Published
August 17, 2016
Content info
74 Pages
Price
USD 2500
Sample available